Characterizing the binding mechanism of Bt (Bacillus thuringiensis) Cry toxin to the cadherin receptor is indispensable to understanding the specific insecticidal activity of this toxin. To this end, we constructed 30 loop mutants by randomly inserting four serial amino acids covering all four receptor binding loops (loops α8, 1, 2 and 3) and analysed their binding affinities for Bombyx mori cadherin receptors via Biacore. High binding affinities were confirmed for all 30 mutants containing loop sequences that differed from those of wild-type. Insecticidal activities were confirmed in at least one mutant from loops 1, 2 and 3, suggesting that there is no critical amino acid sequence for the binding of the four loops to BtR175. When two mutations at different loops were integrated into one molecule, no reduction in binding affinity was observed compared with wild-type sequences. Based on these results, we discussed the binding mechanism of Cry toxin to cadherin protein. 
INTRODUCTION
Bt (Bacillus thuringiensis) is a Gram-positive soil bacterium that produces insecticidal proteins called Cry toxins during sporulation. Cry toxins are specific to insects and do not affect humans and domestic animals. In addition, these toxins are environmentally friendly because they are proteinaceous and easily degrade in the soil and on plant surfaces. Therefore Bt formulations represent pesticides that possess a low impact on human health and the environment. For this reason, Cry toxin genes have been used in the development of GMOs (genetically modified organisms) [1, 2] . However, acquisition of Cry toxins with high insecticidal activity against coleopteran, hemipteran, dipteran and hymenopteran insects from the soil is difficult. The development of a method for engineering Cry toxins with improved insecticidal
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activity against target pests and possessing a broader target pest spectrum is desired. To establish protein-engineering methods for the Cry toxin, the mode of action by which Cry toxin binds to the cadherin receptor must be characterized.
One hypothesis for the insecticidal mechanism of Cry toxins is the pore-forming model [3] . A recent version of the pore-formation model proposed the following sequence of events: protease-activated Cry toxin monomers bind to GPI (glycosylphosphatidylinositol)-anchored proteins, such as APN (aminopeptidase N) and ALP (alkaline phosphatase). This interaction promotes the binding of toxin monomers to the cadherin BtR (Bt receptor), which facilitates protease cleavage of the toxin's N-terminus, including helix α1 of domain I, and induces oligomerization of the toxin. Then toxin oligomers bind with increased affinity to GPI-anchored receptors and create pores in the midgut membrane, leading to osmotic shock and cell death. In contrast, the signalling model hypothesises that an adenylate cyclase/PKA (protein kinase A) signalling pathway is activated by BtR-bound monomer toxins, inducing programmed cell death [4] . Thus, BtR is an important receptor, although the correct hypothesis remains unknown. The generation of various Cry toxin-resistant insect strains has been attributed to a mutation or deletion in BtR [5] [6] [7] [8] . In addition, there have been reports that cultured BtR-expressing insect or human cells are susceptible to Cry1A toxins, thus validating this hypothesis [9] [10] [11] [12] .
Seven 3D (three-dimensional) Cry toxin structures have been determined by X-ray crystallography [13] [14] [15] [16] [17] [18] [19] . Similar 3D structures consisting of three domains (domains I, II and III of the N-terminus) were confirmed to be associated with these toxins. Domain I is composed of a seven-α-helix bundle with a central helix and six surrounding helices, domain II is a β-prism consisting of three antiparallel β-sheets and loops and domain III is a β-sandwich consisting of two antiparallel β-sheets [13, 14, 18] . Loops α8, 1, 2 and 3 of domain II are thought to be BtR-binding regions [20] [21] [22] [23] [24] [25] [26] . However, it is unclear whether all regions are required for binding to BtRs.
A high-efficacy medicine is defined as a compound that can bind to and act on receptors at low concentrations. Accordingly, a major goal for the improvement of a lead medicinal compound is receptor-affinity maturation. Based on this concept, we anticipate that mutant toxins with higher BtR-binding affinities will likely also exhibit higher insecticidal activity. The insecticidal activity of Cry1A toxins is correlated with the binding affinity of Cry1A toxins for BBMV (blush-border membrane vesicles) prepared from insects [27] . Furthermore, binding to BtR has been determined to be indispensable to the insecticidal activity of Cry toxins [28] . Thus, we have developed a genetic-engineering method for improving the binding affinity of Cry toxin for BtR. Indeed, when a Cry1Aa loop suspected to be a BtR-binding site was replaced with that of Cry4Ba, the engineered Cry1Aa lost activity against Manduca sexta and obtained activity against Culex pipiens [29] . Similarly, when Cry4Ba loop 3 was replaced with a Cry4Aa-loop 3-mimic peptide, the engineered Cry4Ba gained activity against C. pipiens, which was originally resistant to Cry4Ba [30] .
Cry1Aa, whose 3D structure has been determined, is active against the easy-bleeding insect Bombyx mori [14] . We have attempted to develop an affinity maturation process for Cry1Aa activity against B. mori BtR (BtR175). This involved applying a directed evolution-based method for the improvement of insecticidal activity using phage display and bio-panning, as described elsewhere [31] . However, as with other toxins, the only information known about this interaction is that the BtR175 binding site of Cry1Aa is near loops 1, 2 and 3 [25, 26] 
EXPERIMENTAL

Bacterial and insect strains
Wild-type T7 phage and Cry toxin displaying phages were propagated and titrated using Escherichia coli BLT-gene10 as described previously [31] . E. coli BL21 was used for the production of the wild-type or mutant Cry1Aa protoxin. Kinshu × Showa, a hybrid race of the silkworm, B. mori was reared as described previously [31] .
Construction of phage libraries
To create Cry1Aa mutants-displaying-phage libraries the regions encoding regions spanning domains II loops to domain III were amplified by PCR using 5 -acgaacccagtattagaaNNNNNNNNNNNNagttttcgtggaatggctcag-3 , 5 -agaaaattttgatNNNNNNNNNNNNggaatggctcag-3 , 5 -tttgatggtagtNNNNNNNNNNNNgctcagagaatag-3 , 5 -tttatactgatgtgNNNNNNNNNNNNaattattggtcagg-3 , 5 -ttatcttcacctNNNNNNNNNNNNattatacttggttc-3 , 5 -tcttcacctttatatNNNNNNNNNNNNcttggttcaggc-3 , 5 -gaagaattataNNNNNNNNNNNNccaaataatcagg-3 , 5 -cttggttcaggcNNNNNNNNNNNNgaactgtttgtc-3 , 5 -ttgagtcatgttNNNNNNNNNNNNcaagcagctggag-3 , 5 -caatgctgagcNNNNNNNNNNNNgcagtttacacct-3 , 5 -gccaagcagctggaNNNNNNNNNNNNttgagagctccaac-3 as sense primers, respectively, for libraries with respect to mutations at 275-278, 278-281, 280-283 of loop α8; 310-313 of loop 1; 365-370, 367-370, 371-374 and 375-378 of loop 2; and 435-438, 439-442 and 443-446 of loop 3 and 5 -agctcattctcgagtgcggccgctctttctaaatcatattctgcctcaa-3 as an antisense primer. Next, the regions encoding domains I-III of Cry1Aa toxin were amplified by PCR using above-described DNA fragments as sense mega-primers and 5 -agaagtattaggtggggatccaatagaaactggttacaccccaa-3 as an antisense primer, digested by restriction enzymes and inserted between BamHI and XhoI sites of T7Select10-3b DNA (Novagen) as described previously [31] .
Preparation of wild-type and mutant toxins
Wild-type and mutant toxins were prepared as described previously. Briefly, DNAs from toxins displayed on the phage were inserted between SpeI and SacI sites of GST (glutathione transferase)-Cry1Aa protoxin fusion-protein expressing vector, pB9 and E. coli BL21 was transformed with each resulting vector [31] . Fusion proteins were harvested as inclusion bodies and solubilized, and then solution of each fusion protein was applied to a DEAE column (Shodex IEC DEAE-825) connected to an HPLC system (Waters 600), and protoxins were activated by 0.5 mg/ml trypsin for 2 h at 37
• C in the column [25] . Activated toxins were eluted using a linear gradient of Tris/HCl buffer and protein concentrations were determined by densitometry using BSA as a standard.
Binding kinetics analysis with SPR (surface plasmon resonance)
Cry1Aa toxin-binding region of BtR175 (BtR175-TBR) was prepared as described previously [32] and immobilized on a CM5 Biacore sensor chip using the amine-coupling method. Eight different concentrations (3.125-200 nM) of mutant Cry toxins diluted in PBST (PBS with 0.005 % Tween 20, pH 7.4) were applied to the surface of the BtR175-TBR-immobilized CM5 sensor chip for 120 s. For dissociation, toxin flow was replaced by PBST, and the response was recorded for at least 240 s. The response curves were fit to a 1:1 Langmuir binding model and analysed using global fitting. Rate constants for association (k a ) and dissociation (k d ) were determined. The sensor chip was regenerated using 30 μl of 10 mM NaOH.
Bioassay using insect larvae
Solubilized GST-protoxin fusion proteins were mixed with artificial diet, Silk Mate PM, resulting in a final concentration of 1.3 μg/g diet. The diets (2.5 g) were placed in 9 cm dishes and then 25 third-instar larvae were reared on each diet at 25
• C. Dead larvae were confirmed after 48 and 72 h.
Activation of toxins with the midgut juice
Activation profile of toxins by the silkworm midgut juice was assessed as described previously [31] . Briefly, midgut juice was prepared from fifth-instar larvae and diluted to be 25 % (v/v) with deionized water. The inclusions of GST-protoxin fusion proteins were mixed with the diluted midgut juice to a final concentration of 1.3 μg/μl. Samples were incubated at 25
• C for 0.5, 1, 2 and 4 h, and subjected to SDS/PAGE.
Preparation of two-site mutants
The region encoding loop 1 to mutated loop 2 was amplified using R 375 GPD 378 mutant DNA as a template and 5 -ttgagtgaatttgttcccggt-3 and 5 -gaaaactccgttccatcaaggacaa-3 , respectively, as sense and anti-sense primers. The region encoding loop 3 was amplified using Q 439 PRG 442 , H 439 MPR 442 or R 443 LGR 446 mutant DNA as templates and 5 -ctgtttgtccttgatggaacg-3 and 5 -aagaaaacgttggagctctca-3 , respectively, as sense and anti-sense primers. Both regions were connected by overlap PCR and resulting DNA fragments were digested by restriction enzymes and then inserted between SpeI and SacI sites of GST-Cry1Aa protoxin fusion-protein-expressing vector, pB9, and E. coli BL21 was transformed with each resulting vector.
RESULTS
Assessment of BtR175 binding affinity of Cry1Aa loop mutants
We have attempted to establish a model system for directed evolution to acquire mutant toxins with higher BtR-binding affinity and higher insecticidal activity using a combination of B. mori and Cry1Aa (Y. Fujii, S. Tanaka, M. Otsuki, Y. Hoshino, H. Endo and R. Sato, unpublished work). As part of this trial, a mutant library was constructed by replacing four serial aminoacid residues with random amino acids at various sites, as described above (Figure 1) . To analyse the role of each of the four loops in the BtR175-binding mechanism of Cry1Aa, more than four phage-displayed Cry1Aa loop-mutants were randomly selected from each library (from each replacement site) and produced in E. coli as inclusions using the fusion protein connected to GST. The mutants were activated by the removal of GST in an anion-exchange column and purified, which resulted in successful acquisition of 30 trypsin-tolerant loop-mutants. BtR175-binding affinities were assessed by Biacore (Figure 2 Figure 2) . All mutants contained different amino acid sequences with respect to the corresponding loop region and no general trend was observed in the amino acid sequence composition compared with the wild-type toxin (Figures 1 and 2 ). (Figure 3) . At least one mutant indicated that insecticidal activity was associated with replacement of the eight sites covering all areas of loops 1, 2 and 3.
Insecticidal activities of the Cry1Aa loop mutants
Defects in the activation process of non-active loop-mutants in larval midgut juice Sequences written in italic are high-affinity-generating mutants derived from our unpublished work. Molecular models were generated using CCP4MG.
(T 439 LRT 442 ) contained only a faint band of activated toxin at 60 kDa ( Figure 4D) . The remaining mutants, as well as the wild-type toxin, had larvicidal activities with stable, activated forms present at 60 kDa. These results indicate the non-activity of R 375 GPD 378 and T 439 LRT 442 owing to a defect in the activation process, resulting in the suggestion that only mutants with defects in the activation process might have lost insecticidal activity. 
Assessment of BtR175 binding affinity of mutants containing double mutations in different loops
DISCUSSION
Replacement of any four sequential amino acids within any of the four loops did not reduce BtR175-binding affinity (Table 1, Figure 2 ). In addition, insecticidal activities remained high in many of these mutants ( Figure 3) . No relationship was observed between the identity of the four replaced amino acid sequences of the mutants and those of the wild-type toxin (Figure 1) . Pigott et al. [33] reported that replacement of loop 1, 2 and 3 regions with CDR3 fragments from human IgG heavy chain did not affect the binding affinity between Cry1Aa and M. sexta BtR (Bt-R1). These results suggest that the amino-acid sequences of the four loops of Cry1Aa are not critical to BtR175 binding. Many proteins do require conserved amino acid sequences for ligand binding. For example, the RGD motif is necessary for the binding of several mammalian extracellular matrix proteins, such as fibronectin, to integrin [34] . However, our results suggest that Cry1Aa activity does not depend on conserved amino-acid sequences in loops, indicating an unusual binding character compared with other proteins.
One binding mechanism that does not require specific aminoacid loop sequences for BtR binding is multipoint attachment. Indeed, loop 2 and 3 of Cry1Aa and loops 2 and α8 of Cry1Ab are reported to have a binding affinity for Bt-R1 [21, 22] , and loops 2 and 3 of Cry1Ab are reported to have a binding affinity for Heliothis virescens BtR [24] . Furthermore, all four loop regions are candidate Cry1A-binding regions for BtRs [25, [35] [36] [37] [38] . Thus, it is possible that these loops bind to BtR by multipoint attachment because replacing a restricted region (four amino acids in one loop) with random amino acids would not be expected to significantly affect BtR-binding affinity, which we observed in the present study.
Even if the multipoint-attachment mechanism applies to Cry toxins, it is reasonable to assume that reduction of the binding site should reduce the binding affinity. However, none of the mutants had a BtR175-binding affinity two times lower than that of wild-type toxins. Indeed, Gomez et al. [21] reported that one of the BtR1-binding sites of Cry1Aa and Cry1Ab includes 367-373 of loop 2, although only two of the seven amino acids overlap between the toxins [21] . It was postulated that aminoacid sequences displaying inverted hydropathic profiles against . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Table 2 BtR175 binding by mutant toxins containing two mutated loops in one molecule Values were obtained by fitting the curves indicated in Figure 5 to a 1:1 Langmuir binding model. [39] . Further, many kinds of volatile compounds with disparate structures can bind to the same odorant binding protein [40] . These phenomena are possible due to conformation changes or the generation of new binding sites.
It has also been reported that loops are flexible in nature, which affects the activities of loop-harbouring molecules. Indeed, the flexible nature of a catalytic loop plays an important role in the activity of a nucleotide hydrolase from Trypanosoma vivax [41] . The flexibility of a loop in E. coli class II fructose-1,6-bisphosphate aldolase was found to be important to its catalytic activity [42] . Cry1Aa loops were reported to be highly mobile and their flexible nature was postulated to play an important role in receptor recognition [14] . It is possible that mutated loops may change conformation to present suitable hydropathic profiles to BtR175, preventing a reduction in BtR175-binding affinity. The sequences of the four loop regions of domain II of Cry1Aa, Ab and Ac generally contain low homology, with exceptionally low homology in loop 2. However, all of these toxins are reported to bind to M. sexta BtR1 [21] . Thus, our experimental results suggest that the high BrR175-binding affinities found for all 30 mutants containing four serially replaced amino acids depend on the flexible nature of the loops. This flexibility may facilitate multipoint attachment by exposing suitable hydropathic profiles for the receptors without the requirement for specially conserved amino acid sequences in the loops. It is conceivable that faster association rates seen in those mutants (Tables 1 and  2 ) could be a consequence of larger conformational flexibility of loops involved in binding, allowing for a larger available fraction of loop conformations compatible with toxin-receptor complex formation.
The loop 2 mutant having an affinity four times higher than that of the wild-type. Initially, it was expected that the integration of these separate sequences into the same mutant toxin would reduce the binding affinity of the mutant for BtR. However, all three mutants containing the two simultaneous replacements maintained higher binding affinity for BtR175 at levels comparable to that of the wild-type toxin ( BtR binding. Moreover, these results indicate that the mutated version containing mutations at both loops 2 and 3 possessed new binding sites for BtR175, which probably resulted from a conformational change in the double mutant. Indeed, Pigott et al. [33] reported that replacing loops 1 and 2, or 2 and 3 simultaneously with CDR3 peptide mutant toxins maintained the binding affinity for Bt-R1 [33] . This is also consistent with the idea that loops do not require specific amino acid sequences for BtR-binding and that newly created loops can form new binding sites.
In the case of scFv (single-chain fragment variable), a mutation generating 133 times higher binding affinity and a mutation derived from a different loop region generating 59 times higher affinity to an antigen were integrated into one molecule, resulting in generation of a 1200 times higher affinity mutant in contrast with the wild-type version [43] . We found that integration of the R 375 GPD 378 mutation (four times higher affinity) with the H 439 MPR 442 mutation (42 times higher affinity) into a R 375 GPD 378 /H 439 MPR 442 double mutant had a resulting binding affinity 49 times higher than that of wild type. These results suggest that the binding affinity of the Cry toxin to the receptor can be increased by integrating two different highaffinity-generating mutations simultaneously into one molecule. Affinity maturation of the Cry1A toxin can be enhanced by introducing several different loop-derived high-affinity-generating mutations into one molecule. In fact, in addition to mutations on loop 3, such as H 439 MPR 442 , we succeeded in finding several mutations on loop 2 containing affinities 20-50 times higher than that of the wild-type toxin. We anticipate the generation of mutants with more than 100 greater binding affinities for BtR than the wild-type toxin by integrating multiple mutations into one molecule.
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